News Release

Created a new Benefit Society called "Cattolica TJU Research" to promote scientific research in the field of Neuroscience, with a new Brain Center project called "Vickie and Jack Farber Institute for Neuroscience at Policlinico Gemelli".

Signed at Policlinico Universitario Agostino Gemelli IRCCS, by Università Cattolica Rector Franco Anelli and Thomas Jefferson University Chief Operating Officer Kathy Gallagher, the agreement to start up a Benefit Society between the two universities. Ell

Business Announcement

Universita Cattolica del Sacro Cuore

"Cattolica TJU Research" is the new benefit society resulting from the agreement signed on Sept. 15, at Policlinico Universitario Agostino Gemelli IRCCS, by Università Cattolica Rector Franco Anelli and Thomas Jefferson University Chief Operating Officer Kathy Gallagher. Its aim is to promote scientific research in the field of Neuroscience, allowing the creation of the Brain Center "Vickie and Jack Farber Institute for Neuroscience at Policlinico Gemelli in Rome," whose project began with the symbolic laying of the foundation stone at Gemelli.

The Thomas Jefferson University (TJU) delegation was formed by Mark Tykocinski, TJU President, Ignazio Marino, TJU Executive Vice President for Jefferson International Innovative Strategic Ventures, Robert Rosenwasser, Professor of Neurosurgery and President of the "Vickie and Jack Farber Institute for Neuroscience," Kathy Gallagher, TJU COO, Robert Di Stanislao, TJU Board member, Drew Morrisroe, TJU Board member, Alfred Salvato, TJU Vice President Finance Department.

Ellen Farber and Bill Farber – who funded the "Vickie and Jack Farber Institute for Neuroscience" - also attended to the event as special guests. They will donate an innovative cyberknife to the Brain Center.

A delegations from the Università Cattolica and the Fondazione Policlinico Universitario Agostino Gemelli IRCCS accompanied the guests on a tour of some of the Polyclinic's facilities dealing with neurological disciplines. This delegation was formed by Paolo Nusiner, General Director of the Università Cattolica and President of Gemelli Isola SpA, Marco Elefanti, General Director of the Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Alessandro Tuzzi, Deputy General Director of the Università Cattolica, and Università Cattolica professors Claudio Grassi, Alessandro Olivi and Paolo Calabresi.

 

The Benefit Society "Cattolica TJU Research"

With the signature of the statute, Catholic University and Thomas Jefferson University established a new benefit society, named "Cattolica TJU Research," with the aim to carry out scientific research in the field of neuroscience. The new Society will offer scientific advice on the use of new clinical equipment, particularly in the field of neuroscience, focusing on the development of new technologies based on the acquisition and processing of neurophysiological data in humans and animals.

"Cattolica TJU Research" will collaborate with national and international universities, organizations and institutions to develop new lines of research in the field of neuroscience, spanning from the design and implementation of software for processing electrophysiological data to research activities, including basic and applied studies. It will also promote and coordinate activities for the design and implementation of knowledge dissemination events.

 

The Brain Center "Vickie and Jack Farber Institute for Neuroscience at Policlinico Gemelli in Rome"

The new Brain Center "Vickie and Jack Farber Institute for Neuroscience at Policlinico Gemelli in Rome," will be the "twin" of the one activated in Philadelphia. It will allow translational and clinical research over the most important neuropsychiatric diseases, as well as cutting-edge treatments of various pathologies, as brain tumors, thanks to the donation by Farber family of a Cyberknife, a leading instrument in the field of radiotherapy.

To achieve those results, a new six-floor building, fully occupied with Neuroscience activities, will be built in front of Gemelli's main building. Radioterapy will occupy the first floor, research labs the second, while the other three floors will host day hospitals, outpatient clinics and treatment rooms for neurology and neurosurgery. In the rooftop there will offices. The building is expected to be completed within two years.

 


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.